Source: Annual Congress 2013 –COPD treatment
Disease area: Airway diseases, Respiratory critical care



Rating:

Share or cite this content

Citations should be made in the following way:
S. Lukyanov, V. Gorbunov, S. Alexeev, M. Lazutkin, T. Aksenova (Chita, Russian Federation). The influence of NIV on the pulse wave velocity in patients with the exacerbation of COPD. Eur Respir J 2013; 42: Suppl. 57, 3675

Member's Comments

No comment yet.

Related content which might interest you: Resting heart rate and exacerbations in COPD patients Source: International Congress 2016 – Biomarkers and phenotypes of COPD Year: 2016 Recording and response to hyperglycaemia in patients presenting with infective exacerbations of COPD Source: Annual Congress 2013 –Difficult and rare respiratory infections Year: 2013 How can time to COPD exacerbation be delayed? A real-world study comparing two oscillating positive expiratory pressure (OPEP) devices in patients with chronic obstructive pulmonary disease (COPD) or chronic bronchitis Source: Virtual Congress 2020 – Inhaler devices in COPD: technical advances, adherence studies and more Year: 2020 PAP therapy impact on COPD exacerbations rate in patients with overlap syndrome Source: International Congress 2015 – To treat or not to treat, and how? Sleep-disordered breathing I Year: 2015 Do patients with recurrent exacerbations of COPD requiring NIV receive higher pressures than those that are NIV naive? Source: Annual Congress 2013 –New evidence for NIV in the acute setting Year: 2013 Importance of the initial behaviour of patients in avoiding late recovery from COPD exacerbations Source: Annual Congress 2013 –COPD: acute exacerbations and others Year: 2013 Frequency of COPD exacerbations and severity of COPD Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations Year: 2013 A pilot study of CPAP therapy for excessive dynamic airway collapse during acute exacerbation of COPD Source: International Congress 2014 – COPD - from biomarkers to novel therapeutic opportunities Year: 2014 Predictors of poor outcome in patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD) receiving noninvasive positive pressure ventilation (NPPV Source: International Congress 2015 – Outcome of noninvasive ventilatory support in acute and chronic respiratory failure Year: 2015 Pulse wave velocity in patients with COPD comorbid with arterial hypertension Source: International Congress 2014 – COPD exacerbations Year: 2014 Long-term non-invasive ventilation in stable COPD patients reduces the rate of hospitalizations for exacerbation Source: International Congress 2015 – Novelties in noninvasive ventilation Year: 2015 Vascular-platelet hemostasis parameters in the stable phase and in acute exacerbation (AE) of COPD Source: International Congress 2015 – COPD: exacerbations, gas exchange and associated dysfunction Year: 2015 COPD: Influence of patients’ nutritive status on the exacerbations rate Source: International Congress 2016 – COPD diagnosis and management Year: 2016 Symptom profile of exacerbations in earlier and later COPD Source: Annual Congress 2013 –Asthma and COPD: diseases with different phenotypes Year: 2013 The effect of tiotropium on exacerbations and airflow in patients with COPD Source: Eur Respir J 2006; 27: 547-555 Year: 2006 Exacerbation and hospitalization in COPD patients with long-term high-intensity NPPV Source: Annual Congress 2007 - Technological progress in noninvasive ventilation Year: 2007 QVA149 reduces COPD exacerbation rate in various subgroups of patients: The SPARK study Source: Annual Congress 2013 –New bronchodilators for COPD management Year: 2013 Characterization of readmissions in patients hospitalized with COPD exacerbation Source: International Congress 2016 – Novel avenues in the treatment of COPD II Year: 2016 A global survey conducted to determine frequency of exacerbations in COPD patients Source: Annual Congress 2013 –COPD treatment Year: 2013 Erdosteine improves airflow in patients with severe exacerbation of COPD (AECOPD) Source: International Congress 2016 – Novel avenues in the treatment of COPD II Year: 2016